ICG (Indocyanine Green)
ICG (Indocyanine Green) is an intervention with 6 clinical trials. Currently 3 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
3
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tumor-Lymph Node Mapping
The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
a Prospective Study of Surgical Results, Complications and Predictive Values in Chinese Women Breast Reconstruction
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
Clinical Trials (6)
Tumor-Lymph Node Mapping
The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
a Prospective Study of Surgical Results, Complications and Predictive Values in Chinese Women Breast Reconstruction
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures
All 6 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 6